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Abstract
Background: The government has made provisions to improve
the nutrition of stunted children under the age of five nationally by
providing iron folic acid (IFA) tablet since conception. However,
these drugs were not able to reduce the incidence of stunted
growth. The aim of this study is to assess the effect of moringa
intervention during pregnancy on the incidence of stunted growth
in children between the ages of 36 to 42 months. 
Design and Methods: This study is a follow-up to an experi-
mental RCT-DB study during pregnancy. The interventions given
were PG (Moringa Flour), EG (Moringa Extract) and IG (IFA)
which was used as control. 
Results: The highest number of children that had stunted
growth after taking the PG by IG and EG extracts were 66
(41.5%), 53 (33.3%) and 40 (25.2%), respectively. The stunted
risk factor analysis did not show a significant relationship to the
stunted incidence. Furthermore, the consumption and dietary pat-
terns of children were based on only fat consumption which was
associated with stunted incidence (p<0.05). The results of multi-
variate analysis showed that the EG extract was effective in reduc-
ing the incidence of stunted growth (p<0.005) and as a protective
factor of 0.431 times the incidence of stunted growth (LL-
UL=0.246-0.754). 
Conclusions: The administration of Moringa oleifera extract
during pregnancy prevents the incidence of stunted growth in chil-
dren.
Introduction
Stunting is still a problem of international and national nutri-
tional health, and every year 3 million deaths are recorded in chil-
dren due to malnutrition. Previous record have shown that around
150.8 million children suffer from stunted growth,1 and this was
found in most African countries and Southeast Asia region.
Furthermore, the stunting rate in the South and Southeast Asia
region is 55.9% and 39.40%.2 Based on the basic health research
survey that was conducted in 2018, it was reported that 30.8% of
children under the age of five suffered from stunted growth in
Indonesia. Furthermore, the highest prevalence of stunted growth
in Indonesia was found in the East Nusa Tenggara province with
69.6%. The stunting rate in South Sulawesi Province was still very
high with 35.7% and it was ranked the 4th highest national stunted
growth prevalence.3 The Research data from several districts
showed that the prevalence of stunted growth in Sulawesi states
varies greatly, with the Malili and Jeneponto districts having
22.1% and 44% in 2018.4,5 However, it was generally concluded
that the problem of stunted growth in South Sulawesi is still high.
Stunted growth reduction programs such as providing inter-
ventions during the period of preconception, pregnancy, and
breastfeeding have been implemented in many developing coun-
tries. This was carried out by improving the quality of breastfeed-
ing mother’s before providing supplementation for 2 years old
children. The ingredients of the intervention are in various types
ranging from chemical properties to supplementations using local
food ingredients. Though the results of these nutritional interven-
tions have not shown consistent results, they have been able to
reduce the prevalence of stunted growth in developing countries.
The prevention of stunted growth needs to be carried out
before conception because it is a chronic nutritional problem.
Previous research has shown that nutritional improvement inter-
ventions during the period of pregnancy are effective in improving
the nutritional status of children under the age of five.6 The gov-
ernment also has made improvements to the national nutrition
intake of children through the provision of iron folic acid (IFA)
tablets during pregnancy. However, this intervention has not been
able to reduce the prevalence of anemia in pregnant women and
stunted growth in children in Indonesia. Therefore, it is necessary
to have an alternative nutritional intervention that reduces the
prevalence of anemia in pregnant women and stunted growth in
children. One of the local foods in Indonesia that has abundant
nutrients is Moringa oleifera.7 Moringa could be used as a local
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food-based nutritional supplement for pregnant women in reducing
the prevalence of anemia and stunted growth in children.8,9
Previous studies have shown that giving moringa to pregnant
women increases the level of iron in their body. It was also shown
that intake of moringa prevents anemia, improves the quantity of
breastfeeding mother, reduce stress and increases the body weight
of pregnant women.10,11
The results of previous study showed the various effect of
moringa intervention on children between the ages of 6 to 24
months. For the PG intervention (p>0.005), children at the age of
six had the highest prevalence of stunted growth with a total num-
ber of 44 (42.7%). While for the EG intervention (p>0.005), chil-
dren at the age of 12 months had the highest prevalence of stunted
growth with a total number of 29 (30.9%). Furthermore, children
at the age 24 months showed that PG intervention was the highest
stunted prevalence which is 57 (48.7) with p>0.05.5,12,13 To sum up
that study, 0 to 24 months of age showed no consistent intervention
effect on stunted incidence. Therefore, this study assesses the
effect of moringa intervention during pregnancy on the incidence
of stunted growth in children between the ages of 36 to 42 months.
Design and Methods
This is a follow-up study of an experimental randomized con-
trol trial-double blind (RCT-DB) study that was conducted during
pregnancy.14 This study was conducted in 6 sub-districts, namely
Bangkala, Tamalatea, Bontoramba, Binamu, Kelara and Tarowang
in Jeneponto District, South Sulawesi, Indonesia. There were 3
forms of capsules that were used, and they include powder
Moringa (PG) 500 mg, extract Moringa (EG) 500 mg and iron folic
acid/Fe 60 mg+0.2 folic acid, which was used as the control
(Tablet Tambah Darah). “Tablet Tambah Darah/TTD” was part of
the government program in improving the nutritional status of
mothers and children and was used as a control for comparing the
effects of the interventions. The intervention was carried out in
third trimester pregnant women that met the inclusion and exclu-
sion criteria, daily for 90 days. The number of pregnant women
that survived and were able to give birth was 440 (single wombs).
However, in the age range of children between 0 to 36 months, the
respondents pulled out of the research leaving the total number of
children that survived to 340 children. This was caused by immi-
gration parents their brought their children to work in urban areas
or overseas. Birth history, breastfeeding and complementary feed-
ing data were used from the follow-up results in previous studies
starting from 0 to 2 years old.5
This study received Ethical Approval from the Ethics
Commission of the Faculty of Public Health, Hasanuddin
University with Protocol Number: 5111993028. Furthermore, the
height, weight, food intake and children’s diet were measured and
collected by enumerators that have been trained. Measurement of
height and body weight was carried out using a microtoise and a
digital scale standardized by the Ministry of Health, Republic of
Indonesia. The measurement of the children’s food intake was car-
ried out using the 24-hour Recall Method and was then converted
into nutrients using the Nutrisurvey 2007 app. Furthermore, the
children’s dietary patterns were measured using the Food
Frequency Questionnaires FFQ () in children aged 36-42 months.
The determination of the HAZ category was carried out using the
WHO Anthro 2005 apps and data was analyzed using SPSS 25 for
Mac.
Results and Discussions
The children between the ages of 34 to 39 months had the
highest number in the EG group with a total of 77 (46.1%), while
those between the ages of 40 to 44 months were in the IG group
with a total number of 70 (43.5%). The bivariate analysis showed
that the intervention group was related to the age children group
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Table 1. Characteristics of children based on the intervention group.
Variables                                            PG (%)                                  IG (%)                                EG (%)                                          p
Age                                                                                                                                                                                                                                                             0.000
        34-39 months                                             46 (27.5)                                          44 (26.3)                                        77 (46.1)                                                       
        40-44 months                                               66 (41)                                            70 (43.5)                                        25 (15.5)                                                       
Sex                                                                                                                                                                                                                                                             0.607
        Male                                                             56 (33.1)                                          63 (37.3)                                        50 (29.6)                                                       
        Female                                                        56 (35.2)                                          51 (32.1)                                        52 (32.7)                                                       
Birth weight                                                          0.245                                                                                                                                                                              
        Low birth weight                                        2 (15.4)                                            7 (53.8)                                          4 (30.8)                                                        
        Normal                                                       110 (34.9)                                          107 (34)                                         98 (31.1)                                                       
Birth length (cm)                                                                                                                                                                                                                                   0.199
        <48                                                               16 (25.4)                                          27 (42.9)                                        20 (31.7)                                                       
        ≥48                                                               96 (36.2)                                          87 (32.8)                                        82 (30.9)                                                       
Breastfeeding first 6 months                                                                                                                                                                                                              0.901
        Non-exclusive                                            48 (33.8)                                          48 (33.8)                                        46 (45.1)                                                       
        Exclusive                                                    64 (34.4)                                          66 (35.5)                                        56 (30.1)                                                       
Complementary feeding                                                                                                                                                                                                                       0.451
        <6 months                                                 26 (33.8)                                          23 (29.9)                                        28 (36.4)                                                       
        ≥6 months                                                  86 (34.3)                                          91 (36.3)                                        74 (29.5)                                                       
Immunization                                                                                                                                                                                                                                          0.225
        Incomplete                                                50 (29.8)                                          63 (37.5)                                        55 (32.7)                                                       
        Complete                                                    62 (38.8)                                          51 (31.9)                                        47 (29.4)                                                       
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(p<0.001). However, the birth weight and length, excluding the
breastfeeding and complementary feeding did not show a signifi-
cant relationship with the intervention group (p>0.05) (Table 1). 
Table 2 shows the highest number of stunted growth in chil-
dren in the PG intervention group witha total number of 66
(41.5%), while the IG and EG groups were 53 (33.3%) and 40
(25.2%). The test results showed a significant relationship between
the intervention group and the incidence of stunted growth in chil-
dren (p<0.05). Other variables which are risk factors for incidence
of stunted growth did not show a significant relationship in this
study (p>0.05). 
Table 3 shows that the energy intake of stunted children was
lower than normal which are 981±455 kcal and 1062±520 kcal.
The results showed that their energy intake was not related to the
incidence of stunted growth (p>0.05). Furthermore, it showed that
the highest fat intake in normal children was more compared to
stunted children, namely 32±25 mg and 27±18. Other nutrient
intake showed no significant relationship with the incidence of
stunted growth (p>0.05). Furthermore, all the types of food pattern
in children showed no significant relationship to the incidence of
stunted growth. Multivariate analysis was conducted to see the
effect and significant value of RR (Relative Risk) between the
intervention groups and the decrease in the incidence of stunted
growth. Furthermore, it also includes other variables that are risk
factors for stunted growth incidence. In the intervention group
using IG as the reference showed that the EG group had a p<0.005.
This means that the EG intervention had an effect on reducing the
incidence of stunted growth (Table 4).
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Table 2. Analysis of factors associated with the stunted incidence.
Variables           HAZ                                  p
                                   Stunted (%)             Normal (%)           
Intervention group                                                                                               
        PG                                       66 (41.5)                           46 (27.2)              0.014
        IG                                        53 (33.3)                           61 (36.1)                  
        EG                                      40 (25.2)                           62 (36.7)                  
Age                                                                                                 
        34-39 months                   82 (49.1)                           85 (50.9)              0.817
        40-44 months                   77 (47.8)                           84 (52.2)                  
Sex                                                                                                 
        Male                                   87 (51.5)                           82 (48.5)              0.262
        Female                              72 (45.3)                           87 (54.7)                  
Weight birth                                                                                                           
        Low birth weight              6 (46.2)                             7 (53.8)               0.864
        Normal                             153 (48.6)                         162 (51.4)                 
Length birth                                                                                                           
        <48                                     33 (52.4)                           30 (47.6)              0.490
        ≥48                                    126 (47.5)                         139 (52.5)                 
Breastfeeding                                                                                                        
        Non-exclusive                  70 (49.3)                           72 (50.7)              0.795
        Exclusive                          89 (47.8)                           97 (52.2)                  
Complementary feeding                                                                                      
        <6 months                        35 (45.4)                           42 (54.4)              0.544
        ≥6 months                       124 (49.4)                         127 (50.6)                 
Immunization                                                                                                         
        Incomplete                       79 (47.0)                           89 (53.0)              0.590
PG, powder Moringa 500 mg; EG, extract Moringa 500 mg; IG, iron folic acid/Fe 60 mg+0.2 folic acid; HAZ,
height of age Z score.
Table 3. Analysis bivariate between food intake of child and stunted.
Food intake       HAZ                                 p
                                        Stunted                   Normal 
                                  (x ̅± SD) / (%)        (x ̅± SD) / (%)        
Energy                                         965±413                          1062±520             0.065
Carbohydrate                              145±69                             150±76               0.528
Fat                                                  27±18                               32±25                0.039
Protein                                          34±21                               37±20                0.156
Zn                                                6.25±3.72                         3.84±2.46             0.402
Fe                                                5.58±2.48                         3.59±3.15             0.301
Folic acid                                      70±57                               68±45                0.764
Vitamin C                                      18±25                               21±34                0.389
Milk intake                                                                                                              
        Low                                    106 (47.5)                        117 (52.5)             0.619
        Enough                               53 (50.5)                          52 (49.5)                  
Egg intake                                                                                                               
        Low                                     45 (39.8)                          68 (60.2)              0.230
        Enough                              114 (53.0)                        101 (47.0)                 
Fish intake                                                                                                              
        Low                                     19 (47.5)                          21 (52.5)              0.895
        Enough                              140 (48.6)                        148 (51.4)                 
Vegetable intake                                                                                                   
        Low                                     26 (34.2)                          50 (65.8)              0.650
        Enough                              133 (52.8)                        119 (47.2)                 
Fruit intake                                                                                                             
        Low                                     94 (49.7)                          95 (50.3)              0.594
        Enough                               65 (46.8)                          74 (53.2)                  
HAZ, height of age Z score.
Table 4. Multivariate analysis of factors affecting the stunted incidence.
Variables                                                        p                                    RR                   95% CI
                                                                                                                                                       Lower limit                         Upper limit
Intervention                                                                                                                                                                                                                                                  
       EG                                                                             0.003                                          0.431                                                      0.246                                                0.754
       PG                                                                             0.291                                          0.743                                                      0.428                                                1.289
       IG                                                                                Ref                                               1                                                           Ref                                                   Ref
Weight birth (<2500 gr)                                             0.750                                          1.209                                                      0.377                                                3.884
Length birth <48 cm)                                                  0.281                                          0.727                                                      0.408                                                1.297
Breastfeeding (no)                                                      0.561                                          0.855                                                      0.505                                                1.449
Complementary feeding (<6 months)                    0.446                                          1.270                                                      0.687                                                2.347
Immunization                                                                0.711                                          1.089                                                      0.694                                                1.707
Mother height                                                               0.116                                          0.659                                                      0.392                                                1.108
Fat consumption                                                           0.052                                          0.558                                                      0.310                                                1.004










This study shows that EG intervention has a significant
effect on reducing the incidence of stunting in children between
the ages of 36 to 42 months. The EG intervention showed the
lowest prevalence of stunting among other interventions such as
the PG and IG. The EG intervention is moringa that was made
through the extraction process. While the PG intervention is
moringa that was made traditionally by drying the leaves and
pounding until it was smooth. During pregnancy, mothers need
to get an adequate supply of nutrients to improve their health
status and also the growth of the fetus.15 Giving moringa extract
to pregnant women provides an abundant supply of micronutri-
ents including Fe, vitamin A, vitamin C, and selenium during
pregnancy. It was known that moringa plants have a lot of
micronutrient and macronutrient nutrients, therefore the
researchers named it the miracle of the tree.7
Most of the pregnant women were deficient in micronutri-
ent nutrients compared to macronutrients during pregnancy.
Moringa extract has sufficient micronutrients compared to
TTD, therefore mothers that consume moringa are filled with
micronutrients. The role of micronutrients such as Fe in
moringa extract provides increased hemoglobin in pregnant
women and also prevent DNA damage due to oxidative stress.11
A study conducted by Sindhu showed that there was a signifi-
cant increase in the hemoglobin level of anemic pregnant
women that were given moringa extract. Therefore, the study
recommended the administration of moringa to prevent iron
deficiency in anemic pregnant women.16
Moringa extract has active chemical substances (phyto-
chemicals) in the form of flavonoids, phytosterols, and steroids
which have anti-inflammatory, anti-carcinogenic, anti-prolifer-
ative, and anti-viral functions.17,18 The content of these phyto-
chemicals in this extract protects the mother from diseases that
could interfere with fetal growth during pregnancy. Therefore,
administering moringa extracts improve the nutritional status of
mothers and affects the placentation and supply of nutrients
from the mother to the fetus.19,20
Improving maternal health during pregnancy provides a
positive response to fetal growth because healthy children are
born to healthy mothers.21 Previous studies have suggested that
the administration of moringa extracts during pregnancy would
prevent children from low birth weight.11 This occurred because
during pregnancy the mother had a good supply of micronutri-
ents from moringa which has a function to increase the growth
of important organs in the fetal phase. Furthermore, the child’s
growth was strongly influenced by the mother’s nutrient intake
in this phase. Whenever the mother’s nutritient level is suffi-
cient, the child gets enough nutrients through the mother’s pla-
centa.22
Apart from pregnant women, the administration of moringa
to children also shows good results on their nutritional status
during the toddler phase. The nutrients in moringa are rich in
protein, Ca, Fe, vitamin C, and carotene, and could be used as
a suitable plant in areas with high prevalence of malnutrition.23
Previous studies have shown that the administration of moringa
could overcome the incidence of malnutrition for children in
their first year.24 Furthermore, a research conducted by Andrew
in the Arusha region, showed that the use of moringa has a sig-
nificant positive effect on the nutritional status of children and
was also able to reduce their morbidity.25 This happens because
the vitamin C and Fe in moringa plays a role in antioxidant
function, which include preventing free radicals that would dis-
rupt the nutritional status of children. Also, iron and other
micronutrients play a role in increasing hemoglobin levels in
children. Srikanth’s research in India stated that giving moringa
to children could also be an alternative in treating protein defi-
ciency.26 This shows the contribution of the abundant amount
and function of the protein in Moringa plants. This study also
shows that there was no difference in the average consumption
pattern of vegetables and fruit in each intervention group.
Therefore, this supports an important role in the availability of
nutritional supplies of children from birth.
There was an average difference between the administration
of EG, PG, and IG to reduce stunting in children. The multivari-
ate analysis shows that the role of EG interventions is signifi-
cant in reducing the incidence of stunting compared to other
interventions. This is because in the IG intervention, the com-
position in it only consists of Fe and folic acid. When compared
with EG intervention which has many abundant nutrients, not
only Fe and folic acid. In terms of quantity, there was only 60
mg of Fe plus 0.2 mg of folic acid in IG. While in EG, based on
the results of laboratory tests at Gajah Mada University,
Indonesia, it was stated that in 100 g of the extract there were
9.72 mg of Fe, 1282 mg of vitamin C and 12.31 grams of pro-
tein. This shows that in terms of nutritional availability between
EG and IG, the nutritional adequacy of mothers that were given
EG was better than IG. Therefore, children born in the EG inter-
vention group were better at preventing stunting compared to
IG.
Furthermore, the difference between EG and PG lies in the
presentation of the moringa supplementation process where EG
uses water extraction and encapsulates it, while PG uses a dry-
ing and refining process before being encapsulated. Based on
previous research, it was shown that 100 grams of PG contain
27.10 grams of protein, 2.30 grams of fat, 16.30 mg of vitamin
A, 17.30 mg of vitamin C, 28.20 mg of Fe, 5.20 grams of Zn,
and no Se.7 Furthermore, for the EG content as previously stat-
ed, 100 gr EG contains 12.31 grams of protein, 18.62 grams of
fat, 313 micro vitamin A, 1282 micro vitamin C, 9.72 grams of
Fe, 3.77 grams of Zn and 47 mg of Selenium. Therefore, the
nutritional content of PG is more than EG in the nutritional con-
tent of Protein, Fe, and Zn. However, EG provides an abun-
dance of nutrients that are more numerous and varies, for exam-
ple in fat, vitamin A, vitamin C, and selenium nutrients that are
not found in PG. Based on the nutritional value, the nutrients in
EG are more diverse compared to PG. The difference in nutrient
content makes a significant effect on the growth of the fetus in
children and during breastfeeding.
Furthermore, several research articles show that the extract-
ed form has greater advantages than the flour form. In the pro-
cess of obtaining nutrients in the form of flour during the
extraction process, several phytochemicals were found in the
extracted material. Phytochemicals are active chemicals con-
tained in a plant. Based on previous research, it was shown that
EG has phytochemical ingredients such as flavonoids, saponins,
alkaloids, tannins, and phenols.19 These phytochemicals are of
several benefits for humans. For example, flavonoids are found
to have a large anti-oxidant function and increase urination and
electrolyte excretion, which functions like potassium that
absorbs electrolyte ions.27 In addition, the phenolic chemicals
in moringa are multi-functional compounds that are useful for
pregnant women and children in preventing cell damage, dis-
eases and aging.28
Previous research also shows that giving EG to pregnant
women increases the quantity of their breast milk. The presence
of abundant fat in moringa contributes to the formation of fatty
acids which are very beneficial for nursing mothers. These fatty
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acids include Arachidic Acid (AA), Alfa Linoleic Acid (ALA),
and Linoleic Acid (LA). The interaction and conversion in the
body between ALA and LA form the Docosahexaenoic Acid
(DHA), while the conversion from LA forms AA. DHA and AA
play a major role in the growth and development of body tissues
in children during toddlerhood. Previous studies have showed
that the levels of DHA and AA in EG intervention were greater
than PG, namely DHA = 38.20 ph/mL, AA = 180.16 ug/m and
DHA = 33.37, AA = 176 ug/m. Therefore, this made the nutri-
tion intervention in the form of EG to become better at reducing
the incidence of stunting than the other two interventions,
namely PG and IG.29
The external and internal factors of children that could
influence the relationship between the interventions and the
incidence of stunting were also measured to control the effect of
these factors. They are risk factors for stunting including a long
history of birth weight and length, consumption patterns, and
children’s intake. Based on the data collected, this study
showed that birth weight and length, and differences in the
average history of breastfeeding and complementary feeding in
each intervention group were not associated with the incidence
of stunting. Apart from not giving a relationship to the inci-
dence of stunting, this factor does not have a significant differ-
ence in the proportion of each intervention group. The amount
of nutritional intake for children shows that only fat nutrients
are associated with the incidence of stunting. However, after the
multivariate analysis was carried out to control the confounding
variables, it was found that fat consumption did not significant-
ly influence the relationship between EG intervention and the
incidence of child stunting. This explains that these risk factors
do not provide a simultaneous relationship to the incidence of
child stunting in this study.
A research on the nutritional supplementation in pregnant
women has been carried out but the results of these interven-
tions are still very mixed. In this 5-year study, various types of
nutrition interventions were also carried out during pregnancy
and there was a closer attention at the effects on the growth of
children between the ages 0 to 5 years. However, there have
been no significant result in reducing the incidence of stunting
in children at the age of 36 to 42 months.30 Therefore, the
results of this study could be a solution to the problem of the
nutrition intake of children and mothers in areas that have a
high prevalence of stunted growth and anemia.
Conclusions
Administering EG supplementation during pregnancy pre-
vents stunting compared to IG and IFA in children between the
ages of 36 to 42 months. Therefore, it is recommended that
pregnant women should consume moringa during pregnancy.
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